shingles Archives -

Seattle, US vaccine startup Curevo has raised $60 million in first-round financing that it says will be used

Vaccines upstart Curevo has designs on blockbuster GSK franchise

https://pharmaphorum.com/news/vaccines-upstart-curevo-has-designs-on-blockbuster-gsk-franchise/

GlaxoSmithKline places its shingles vaccine Shingrix among its top prospects, with peak sales potential of almost $6 billion.

Look out GSK, Pfizer and BioNTech are coming for Shingrix

https://pharmaphorum.com/news/look-out-gsk-pfizer-and-biontech-are-coming-for-shingrix/

The FDA has approved GlaxoSmithKline’s shingles vaccine Shingrix for use in people aged under 50 who are immunocompromised

GSK wants to double Shingrix sales, and a new FDA okay could help

https://pharmaphorum.com/news/gsk-wants-to-double-shingrix-sales-and-a-new-fda-okay-could-help/

Shingrix has billion dollar sales potential, according to analysts.

GSK files shingles vaccine in EU

https://pharmaphorum.com/news/gsk-files-shingles-vaccine-eu/

Shingrix has blockbuster potential, according to analysts.

GSK files shingles vaccine in US

https://pharmaphorum.com/news/gsk-files-shingles-vaccine-us/

shingles